Northern Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.53B | Buy |
|
|||||
2025
Q1 | $1.58B | Buy |
|
|||||
2024
Q4 | $1.55B | Buy |
|
|||||
2024
Q3 | $1.57B | Sell |
|
|||||
2024
Q2 | $1.59B | Sell |
|
|||||
2024
Q1 | $1.6B | Sell |
|
|||||
2023
Q4 | $1.72B | Sell |
|
|||||
2023
Q3 | $2.09B | Buy |
|
|||||
2023
Q2 | $2.31B | Sell |
|
|||||
2023
Q1 | $2.7B | Sell |
|
|||||
2022
Q4 | $3.42B | Buy |
|
|||||
2022
Q3 | $2.91B | Sell |
|
|||||
2022
Q2 | $3.51B | Buy |
|
|||||
2022
Q1 | $3.44B | Sell |
|
|||||
2021
Q4 | $4.01B | Buy |
|
|||||
2021
Q3 | $2.92B | Buy |
|
|||||
2021
Q2 | $2.52B | Sell |
|
|||||
2021
Q1 | $2.36B | Sell |
|
|||||
2020
Q4 | $2.46B | Sell |
|
|||||
2020
Q3 | $2.52B | Sell |
|
|||||
2020
Q2 | $2.25B | Sell |
|
|||||
2020
Q1 | $2.29B | Sell |
|
|||||
2019
Q4 | $2.79B | Sell |
|
|||||
2019
Q3 | $2.62B | Sell |
|
|||||
2019
Q2 | $3.31B | Sell |
|
|||||
2019
Q1 | $3.26B | Sell |
|
|||||
2018
Q4 | $3.4B | Buy |
|
|||||
2018
Q3 | $3.3B | Sell |
|
|||||
2018
Q2 | $2.76B | Sell |
|
|||||
2018
Q1 | $2.78B | Sell |
|
|||||
2017
Q4 | $2.89B | Sell |
|
|||||
2017
Q3 | $2.89B | Buy |
|
|||||
2017
Q2 | $2.61B | Sell |
|
|||||
2017
Q1 | $2.7B | Sell |
|
|||||
2016
Q4 | $2.61B | Sell |
|
|||||
2016
Q3 | $2.79B | Buy |
|
|||||
2016
Q2 | $2.88B | Sell |
|
|||||
2016
Q1 | $2.45B | Sell |
|
|||||
2015
Q4 | $2.67B | Sell |
|
|||||
2015
Q3 | $2.78B | Sell |
|
|||||
2015
Q2 | $3.05B | Sell |
|
|||||
2015
Q1 | $3.18B | Sell |
|
|||||
2014
Q4 | $2.91B | Sell |
|
|||||
2014
Q3 | $2.78B | Sell |
|
|||||
2014
Q2 | $2.83B | Sell |
|
|||||
2014
Q1 | $3.09B | Sell |
|
|||||
2013
Q4 | $3.02B | Sell |
|
|||||
2013
Q3 | $2.86B | Sell |
|
|||||
2013
Q2 | $2.89B | Buy |
|